PTGX
PTGX
NASDAQ · Biotechnology

Protagonist Therapeutics Inc

Mid-Cap Stocks Biotech Stocks Healthcare Stocks
$144.98
+1.98 (+1.38%)
As of Sep 21, 9:53 PM ET ·
Analyst Consensus
Strong Buy
20
Analysts
High
Coverage
Buy 19 95%
Hold 1 5%
Sell 0 0%
Price Target
Analyst Price Target -79.0% upside
Low Target $24.78
Average Target $30.47
High Target $49.57
Current Price $144.98
Current
$144.98
Target
$30.47
$24.78 $30.47 avg $49.57
Scenario Analysis
Bear Case
$24.78
-82.9%
Low target
Base Case
$30.47
-79.0%
Avg target
Bull Case
$49.57
+-65.8%
High target
Risk/Reward
0.8x
Unfavorable
Price in Context
52-Week High
$160.81
-9.8% from high
52-Week Low
$58.91
+146.1% from low
50-Day SMA
$85.10
+70.4% vs SMA
200-Day SMA
$67.75
+114.0% vs SMA
RSI (14)
58.3
Neutral
Target vs 52W High
$30.47
-81.1% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Strong Buy 39 82% $257.58 -2.6%
AMGN
Amgen Inc
 Hold 43 47% $190.87 -51.5%
GILD
Gilead Sciences Inc
 Strong Buy 37 81% $362.68 +140.9%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 36 81% $438.34 -14.2%
REGN
Regeneron Pharmaceuticals
 Buy 38 68% $76.80 -90.4%
MRNA
Moderna Inc
 Hold 30 37% $149.45 -13.6%
NTRA
Natera Inc
 Strong Buy 30 87% $142.91 -61.4%
RVMD
Revolution Medicines Inc
 Strong Buy 28 93% $114.11 -40.8%